0
2022
Cerebral Palsy Treatment Market

Cerebral Palsy Treatment Market

by Drug Type (Anticholinergics, Anticonvulsants, Antidepressants, and Others), Disease Type (Spastic Cerebral Palsy Treatment, Dyskinetic Cerebral Palsy Treatment, Ataxic Cerebral Palsy Treatment, and Mixed Cerebral Palsy Treatment), Distribution Channel (Hospital pharmacies, Retail Stores & Pharmacy, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2030

Report Code: A13340
Pages: 274
Feb 2022 | 1125 Views
Author(s) : Suraj Sajeev, Sanjivan Gill, Ajinkya Alhat , Onkar Sumant
Tables: 122
Charts: 44
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cerebral Palsy Treatment Market

Request Now !

Cerebral Palsy Treatment Market Insights 2030:

The global cerebral palsy treatment market size was valued at $3166.82 million in 2020, and is projected to reach $4,365.01 million by 2030, registering a CAGR of 3.3% from 2021 to 2030. Cerebral palsy is a combination of different disorders that effect a person’s ability to maintain posture caused majorly, owing to abnormalities in the brain. Apart from movement and posture, a person suffering from cerebral palsy may witness problems with hearing, speech, changes in spine such as scoliosis or joint problems including contractures. Four major types of cerebral palsy are prevalent across the globe. 

The COVID-19 pandemic has led to disruptions in the healthcare system. Although community-dwelling individuals with disability were given special permission to go out, physical therapy and rehabilitation services were disrupted. Patients suffering from cerebral palsy had to switch to tele-medicine during the lockdown as they couldn’t visit the hospitals.

Spastic cerebral palsy effects muscle stiffness resulting in awkward movements. The stiffness occurs in legs and arms. This leads to difficulty in walking due to tight leg muscles. Vice versa in dyskinetic cerebral palsy, people have problems with controlling hand and arm movements, making it difficult to walk and do stuff. Furthermore, ataxic cerebral palsy leads to balancing issues, resulting in unsteady movements. Early symptoms of cerebral palsy include stiffness and loopside crawling. 

Cerebral-Palsy-Treatment--Market

Cerebral palsy diagnosis involves developmental monitoring, which involves tracking patient’s development over time, developmental screening in which a short test is given to figure out whether the patient suffers from any developmental delays such as movement or motor skill delays. In case the doctor finds discrepancies, referrals are made pertaining to further evaluations. Further treatment involves intervention services, which include specialized government–NGO-collaborated plans. Rise in incidents of cerebral palsy and related chronic diseases, coupled with rising awareness on advanced therapeutics for quick treatment is anticipated to drive cerebral palsy treatment market growth in coming years.

Increase in healthcare expenditure sourced by both government treasuries and private sector investments, coupled with growing shift toward new age technologically integrated healthcare mechanisms are further expected to boost the market growth for cerebral palsy treatment medications. This trend is more likely to be witnessed in regions with growing purchasing power parity. Rising demand for more research and development investments pertaining to pharmaceutical industry is anticipated to further propel the market growth for cerebral palsy treatment. 

Acute side effects associated with administration of drugs pertaining to cerebral palsy may hamper the market growth. In addition, conception of nonsurgical treatments such as physiotherapy and rehabilitation centers, coupled with decline in focus from surgical procedures in industrialized regions hamper market penetration of cerebral palsy treatment surgeries.

Impact Of Covid-19 On Cerebral Palsy Treatment Market (Pre And Post Analysis)

The COVID-19 outbreak is anticipated to have a negative impact on growth of the global cerebral palsy treatment market. The COVID-19 pandemic has stressed healthcare system in the world and increased the need to identify the strain of new coronavirus. During the lockdown, patients faced an interruption of their ongoing treatment. Although community-dwelling individuals with disability were given special permission to go out, physical therapy and rehabilitation services were disrupted. Patients suffering from cerebral palsy had to switch to tele-medicine during the lockdown as they couldn’t visit the hospitals.

Cerebral Palsy Treatment Market Segmentation

The report segments the cerebral palsy treatment market based on drug type, disease type, distribution channel, and region. Based on drug type, it is classified into anticholinergics, anticonvulsants, antidepressants, and others.

Cerebral Palsy Treatment Market
By Drug Type

Your browser does not support the canvas element.

Anticonvulsants segment dominated the market in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Based on disease type, it is classified into spastic cerebral palsy, dyskinetic cerebral palsy, ataxic cerebral palsy, and mixed cerebral palsy. Based on distribution channel, the market is divided into hospital pharmacies, retail stores and pharmacies, and online providers. Based on the region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment review

By drug type, the anticonvulsants segment currently dominates the global cerebral palsy treatment market and is expected to continue during the forecast period owing to increasing prevalence rate of cerebral palsy, and rise in the approval of anticonvulsant drugs from the U.S. Food and Drug Administration (FDA). By disease type, the spastic cerebral palsy segment dominated the global cerebral palsy treatment market in 2020, as around 80% of the total cerebral palsy patients are suffering from spastic cerebral palsy.

Cerebral Palsy Treatment Market
By Disease Type

Your browser does not support the canvas element.

Spastic cerebral palsy segment held a dominant position in 2020.

Get more information on this report : Request Sample Pages

By distribution channel, the retail stores and pharmacies segment dominated the global cerebral palsy treatment market in 2020 and is anticipated to grow owing to recent upgrades in the pharmaceutical sector, increase in expenses on the health & medicines, easy access to pharmaceuticals for the general population, rise in awareness for cerebral palsy disorders thereby encouraging the treatments, and boost in the health insurance penetration. 

Cerebral Palsy Treatment Market
By Distribution Channel

Your browser does not support the canvas element.

Retail Stores & Pharmacy segment held a dominant position in 2020.

Get more information on this report : Request Sample Pages

Region Segment Review

Region wise, North America dominated the cerebral palsy treatment market in 2020, owing to significant rise in investments as well as partnerships and collaborations. However, Asia-Pacific is expected to witness considerable market growth during the forecast period, due to increase in number of initiatives along with enhanced investments for the overall R&D of cerebral palsy treatment. Moreover, India and China are expected to grow at high CAGR in the Asia-Pacific medical device outsourcing market.

The key players in this market have adopted product launch as one of their key developmental strategies. The major companies profiled in this report include Merz Pharmaceuticals, LLC., Pfizer Inc., Teva Pharmaceuticals, Bayer AG, Johnson & Johnson, GlaxoSmithKline plc., Novartis, AbbVie Inc., Par Pharmaceutical, Allergan plc., Lannett Company, Inc.

Cerebral Palsy Treatment Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia- Pacific region would exhibit the fastest CAGR of 4.5% during the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global cerebral palsy treatment market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the cerebral palsy treatment market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing cerebral palsy treatment market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of cerebral palsy treatment used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the cerebral palsy treatment market.

Cerebral Palsy Treatment Market Report Highlights

Aspects Details
By Drug Type
  • Anticholinergics
  • Anticonvulsants
  • Antidepressants
  • Other
By Disease Type
  • Spastic Cerebral Palsy
  • Dyskinetic Cerebral Palsy
  • Ataxic Cerebral Palsy
  • Mixed Cerebral Palsy
By Distribution Channel
  • Hospital Pharmacies
  • Retail stores and Pharmacy
  • Online Providers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
List of key players profiled in the report:
  • Merz Pharmaceuticals, LLC.
  • Pfizer Inc.
  • Teva Pharmaceuticals
  • Bayer AG
  • Johnson & Johnson
  • GlaxoSmithKline plc.
  • Novartis
  • AbbVie Inc.
  • Par Pharmaceutical.
  • Allergan plc
  • Lannett Company, Inc.
 

Loading Table Of Content...


 
 

According to the Analyst’s perspective, the utilization of cerebral palsy treatment is projected to witness a significant rise with growth in number of cerebral palsy patients across the globe. It is expected to witness high demand for the medications, owing to rise in cases of cerebral palsy patients. The cerebral palsy treatments are getting better and more advanced than its predecessors, owing to rising activities in the R&D segments of the key players. The cerebral palsy treatment market has gained momentum in the research, innovation, and development sectors, owing to surge in the number of cerebral palsy across the globe, significant technological advancements, and surge in the product launches, business expansions & FDA approvals among manufacturing companies and other organizations. In addition, rise in awareness regarding the cerebral palsy treatments and its advantages supplement the market growth. North America is expected to present lucrative growth opportunities to the key players in the industry.

The demand of chronic kidney diseases has increased significantly due to rising cases of patients. Moreover, the introduction of novel drugs and improvements in the existing products are propelling the market growth. However, side effects associated with the drugs are proving a big challenge for the global market. According to the Analyst, the utilization of cerebral palsy treatment is higher in hospitals as compared to other distribution channels. In addition, cerebral palsy medication manufacturers, developers, and distributors have focused on expanding their presence in emerging economies to expand their market outreach.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Cerebral palsy is a group of disorders that affect a person’s ability to move and maintain balance and posture.

A. The total market value of Global Cerebral Palsy Treatment Market is $3,166.82 million in 2020.

A. The forcast period for Global Cerebral Palsy Treatment Market is 2021 to 2030.

A. The market value of Global Cerebral Palsy Treatment Market in 2030 is $4,365.01 million.

A. Merz Pharmaceuticals, LLC., Pfizer, Inc., Teva Pharmaceuticals, Bayer AG, and Johnson and Johnson held a high market postion owing to the strong geographical foothold in different regions.

A. Spastic Cerebral Palsy Treatment segment dominates the global market, as around 80% of the total cerebral palsy patients are suffering from spastic cerebral palsy.

A. The major factor for the growth of Global Cerebral Palsy Treatment Market are increase in incidences of cerebral palsy and rise in the investment by key players.

A. Owing to rise in the geriatic population in the market. Furthermore, initiatives by governments for regulatory approvals.

A. The base year is 2020 in Global Cerebral Palsy Treatment Market.

A. Cerebral Palsy treatments are used for the treatments of cerebral palsy disorder.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Free Sample

OR

Purchase Full Report of
Cerebral Palsy Treatment Market

Start reading instantly.
This Report and over 18,758+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Feb 2023 - Feb 2024)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers